Wuhan Sunrise Technology Development Company limited is a high-tech pharmaceutical enterprise dedicated to R&D of chemical drug. The main business are R&D, technology transfer and technical services of APIs and pharmaceutical intermediates; R&D, manufacture and sales of PIs. Moreover, we have the right of dealing self-managed imp & exp business.

We have researching centers one in Wuhan and one in Dalian for chemicals production with output from mg to kgs, and we also have cooperated factories in Qufu of Shandong and Guan of Anhui for bulk production.

In 2012, we established the biological lab for offering biological pharmaceuticals such as Trastuzumab, Cetuximab, Rituximab and so on for pharmaceutical R&D usage. We can support by offering the API grade for customers researching or applying for Drug Administration, also we can support with the biological API and finished dosage technology. We also have close cooperation with some GMP certified pharmaceutical factories, some Universities and Research Institutes .

Our products are well sold not only across our China but also into many European, American and southeast Asia countries. We are striving to offer all our customers excellent service, excellent business and excellent price.

Main products:

• Chemical synthesis series:
• Anti-cancer pharmaceutical intermediates,
• Ophthalmology APIs and related intermediates
• Biological series: Mabs
• Fermentation: Mitomycin C, Milbemycin oxime, Neomycin sulfate and so on